CLOV CLOVER HEALTH INVESTMENTS CLASS A
Health Care · Russell 2000
Next earnings: not announced yet
What 7 analyst firms say about CLOVER HEALTH INVESTMENTS CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
6 rated views · 7 analyst/firm records · 7 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 5 reports on CLOV from 5 analyst firms in the last 90 days (7 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: UBS raised its target from $5.00 (set 6 Aug 2026) to $5.50 on 5 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Canaccord Genuity | Richard Close | Buy | 21 Jul 2026 | 5.50 USD |
| Deutsche Bank | Unnamed analyst | Buy | 10 Sep 2026 | 6.00 USD |
| Leerink Partners | Whit Mayo | Hold | 6 Aug 2026 | 5.00 USD |
| Needham | Matthew Shea | Buy | 28 Oct 2026 | 6.00 USD |
| UBS | Jonathan Yong | Hold | 6 Aug 2026 | 5.00 USD |
| Weiss Ratings | Unnamed analyst | — | 21 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 14 Sep 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 05:55 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.